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Abstract
Background: Skin diseases are a major health problem. Some of the most severe conditions involve genetic
disorders, including cancer. Several of these human diseases have been modelled in genetically modified mice,
thus becoming a highly valuable preclinical tool for the treatment of these pathologies. However, development of
three-dimensional models of skin using keratinocytes from normal and/or genetically modified mice has been
hindered by the difficulty to subculture murine epidermal keratinocytes.
Methods: We have generated a murine epidermal cell line by serially passaging keratinocytes isolated from the
back skin of adult mice. We have termed this cell line COCA. Cell culture is done in fully defined media and does
not require feeder cells or any other coating methods.
Results: COCA retained its capacity to differentiate and stratify in response to increased calcium concentration in
the cell culture medium for more than 75 passages. These cells, including late passage, can form epidermis-like
structures in three-dimensional in vitro models with a well-preserved pattern of proliferation and differentiation.
Furthermore, these cells form epidermis in grafting assays in vivo, and do not develop tumorigenic ability.
Conclusions: We propose that COCA constitutes a good experimental system for in vitro and in vivo skin
modelling. Also, cell lines from genetically modified mice of interest in skin biology could be established using the
method we have developed. COCA keratinocytes would be a suitable control, within a similar background, when
studying the biological implications of these alterations.
Background
Skin diseases affect patients of all ages worldwide. By
some estimates, they affect 50 percent or more of the
population at any one time and comprise over 2,000
medical conditions which can range from only mild skin
problems to pathologies that are serious or even fatal.
The aetiology of skin diseases is varied and some of the
most severe are autoimmune and genetic disorders,
including cancer.
Skin tissue engineering techniques emerged in the
1980s to address the need for extensive full-thickness
burns coverage in the absence of sufficient autologous
skin for grafting [1-3]. In the clinical context they are
also useful in treating non-healing ulcers [4,5]. In addi-
tion to its clinical applications, three-dimensional
models (3D) of engineered skin are being broadly used
in skin biology research, such as reducing animal experi-
mentation (i.e. animal testing for human skin products),
investigation of cell interactions and skin barrier pene-
tration, and the development of models of human skin
diseases, such as psoriasis [6-8] and the genetic disorder
epidermolysis bullosa [9,10].
Over the last years, genetically modified (transgenic
and/or null) mouse models have been developed that
recapitulate to a variable extent human diseases, includ-
ing skin disorders. There is a lot to learn from engi-
neered epidermis using keratinocytes from these animal
models. However, despite the early success in culturing
human keratinocytes [11], primary murine keratinocytes
have shown to be fairly reluctant to subculture and
expansion in vitro, thus precluding the establishment of
reproducible 3D models to be used in skin biology
research. Initial attempts to culture murine keratinocytes
long-term required the use of matrix coated dishes and/
or complex fibroblast-conditioned media with fetal
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cells retained their ability to differentiate, when the con-
centration of calcium in the culture media was
increased, only until passage 10 [12] to 15 [14]. Caldelari
et al. [15] and Reichelt & Haase [16] achieved serial
subculture of murine epidermal keratinocytes for more
than 50 and 250 passages, respectively. While Reichelt &
Haase method still required the use of feeder cells in the
initial phases of growth, collagen-coated dishes and
serum-conditioned culture media, Caldelari et al. [15]
subcultured cells in uncoated culture dishes and fully
defined media. Also, they showed that their cell line
retained the capacity to respond to the elevation of cal-
cium concentration in the culture media with the estab-
lishment of intercellular adhesion complex and the
expression of terminal differentiation markers.
There has been great advance in the development of
fully defined media to culture keratinocytes and to
establish 3D epidermal models; however, theses
advances are being focused and tested on primary
human epidermal keratinocytes. In fact, when compared
to the field of human tissue-engineered skin (for a
review [17]), current experience on 3D models using
cultured murine keratinocytes is scarce, consisting of
organotypic cultures that use devitalised dermis and
complex non-defined culture media [13,18].
We have established a murine keratinocyte cell line
that grows on conventional cell culture plastic dishes
and with defined culture media. These cells retain its
potential to differentiate for more than 75 passages
when the calcium concentration is increased, and form
an epidermis-like structure using the abovementioned
3D protocols. This murine cell line, termed COCA, is
non-tumorigenic and can also form an epidermis in vivo
when grafted onto immunodeficient mice. We propose
that our cell culture technique is suitable for the estab-
lishment of other murine cell lines bearing different
genetic manipulations and that these cell lines can be
used to establish reproducible 3D epidermal models
appropriate for skin biology research.
Methods
Cell isolation and culture
Keratinocytes were isolated from the back skin of 2-
months old C57BL/DBA mice using a protocol suitable
for adult skin [19]. They were maintained in culture in a
low calcium (0.07 mM) progenitor cell targeted fully
defined media, CnT-07 (CELLnTEC, Bern, Switzerland),
in an incubator at 37°C and 5% CO2.A tc o n f l u e n c y ,
cells were subcultured by trypsinisation and plated at
4.5-5.5 × 10
3 cells per cm
2 in seeding media (EMEM,
4% FBS pre-treated with Chelex 100 resin, 0.2 mM
CaCl2) for 8-14 hours to allow cell adhesion. Then, cul-
ture plates were washed twice with PBS to eliminate
calcium, and switched to CnT-07 to promote cell
growth and prevent differentiation. FBS-seeding media
is not further needed once the cell line has been estab-
lished (>20 passages). At this point, 8-14 hours incuba-
tion in CnT-07 medium containing 0.2 mM CaCl2 is
enough to ensure good cell attachment after
trypsinisation.
Conventional in vitro keratinocyte differentiation was
initiated when cells were confluent by changing the low
calcium (0.07 mM) media to a high calcium (1.2 mM)
differentiation media. This elevation in the concentra-
tion of calcium induces the cells to differentiate [20-22].
Bromodeoxyuridine 10 μM (BrdU) (Sigma Aldrich, St.
Louis, MO) was added to the culture medium 1 hour
before sample fixation.
Three-dimensional (3D) in vitro e p i d e r m a lc e l lc u l -
tures were established by culturing COCA in CELLn-
TEC fully defined cell culture media following the
manufacturer’s recommendations, in the absence of
fibroblasts or other supporting cells. Briefly, 200,000
cells were seeded into Millipore PCF 0.4 μmi n s e r t s
placed in a Petri dish. Cells were grown for four days in
CnT-07, and switched to CnT-02-3D when they reached
confluency. Culture media in and outside the inserts
was left for an overnight; then, culture media inside the
inserts was aspirated to start the stratification process.
This system creates an air/liquid interface that allows
the formation of a multilayered structure with a popula-
tion of proliferative cells in the basal layer and a differ-
entiated progeny. CnT-02-3D media was changed every
2-3 days. Development of 3D epidermal cell cultures
was followed for 3 weeks.
Mice
All the animal work was approved by the Animal Ethical
Committee (CEEA) and conducted in compliance with
Centro de Investigaciones Energéticas, Medioambietales
y Tecnológicas (CIEMAT) guidelines. NMRI nude (nu/
nu) immunodeficient 5-week old female mice were
obtained from Janvier (Saint-Berthevin, France) and
housed in our animal facilities for 1-2 weeks prior to
any experimental procedures. Mice were injected intra-
peritoneally with 100 μg of BrdU (dissolved in 0.09%
NaCl) per g of body weight 1 hour before they were
sacrificed to analyse proliferation (BrdU incorporation).
Tumorigenicity assay
To assay tumour-formation ability, 1 × 10
6 COCA cells
in late passages (>70) were resuspended in 100 μl saline
buffer and injected subcutaneously on the flanks of
NMRI nude mice. Both flanks were used, in one COCA
were injected alone, in the other they were combined
with 0.5 × 10
6 dermal fibroblasts. The experiment was
repeated three times using 5 mice (x2 flanks) per
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mals were sacrificed and studied at 4-6 months to
search for any indication of tumour.
Cell grafting assay
To assay the ability of COCA cells to engraft we fol-
lowed a protocol adapted from Strachan and Ghadially
[23]. Briefly, mice were anesthetised and an excision
approximately 5 mm in length was performed in the
dorsal skin just between the shoulder blades. Silicone
chambers with a 7 mm internal diameter (Renner,
Dannstadt, Germany) were implanted and sutured in
place when required. COCA epidermal keratinocytes
(1.5 × 10
6) in passage 77 were mixed with dermal fibro-
blasts (0.5 × 10
6), resuspended in a final volume of 100
μl PBS and injected into the silicon chambers. The cells
were allowed 20 min to settle and adhere before waking
up the mice. Epidermis formed by grafted COCA +
fibroblasts was harvested 4 weeks after chamber implan-
tation. Mice were injected i.p. with 100 μg/g of body
weight BrdU 1 h before they were sacrificed to analyse
proliferation.
Histological procedures
For histological analysis, cells and tissue samples were
fixed in 4% paraformaldehyde and embedded in paraffin
prior to sectioning. Sections 3-4 μm thick were stained
and processed as described [24]. For BrdU detection,
prior to blocking with serum, samples were incubated
for 30 min in 1 N HCl (cells) or 1 h in 2 N HCl (tissue).
Primary antibodies used were rabbit polyclonal anti-K5,
anti-K6, Loricrin, Filaggrin (Covance, Emeryville, CA),
and anti-BrdU (AbCam, Cambridge, UK); and mouse
monoclonal anti-K10 (for cells clone RKSE60, St. Cruz
Biotechnology, Santa Cruz, CA; for tissue sections DE-
K10, DakoCytomation, Denmark A/S) and anti-PCNA
(clone PC10 Thermo Scientific, Fremount, CA). FITC or
TexasRed conjugated secondary antibodies were pur-
chased from Jackson ImmunoResearch (West Grove,
PA). Control slides were obtained by replacing primary
antibodies with PBS or preimmune sera.
Results
Establishment of a long-term culture of murine epidermal
keratinocytes
Keratinocytes were isolated from the back skin of 2-
months old C57BL/DBA mice and maintained in culture
in low calcium (0.07 mM) fully defined media (CnT-07).
Cells were repeatedly passaged to establish a cell line.
We termed this murine epidermal keratinocyte derived
cell line COCA, and we have expanded it in culture for
more than 80 passages. COCA cell line has been depos-
ited (October 2010) under the reference 10112001 with
ECACC (European Collection of Cell Cultures, http://
www.hpacultures.org.uk/products/celllines/generalcell/
detail.jsp?refId=10112001&collection=ecacc_gc).
Cytogenetic studies using the spectral karyotype (SKY)
(Table 1 and Additional file 1) revealed that a transloca-
tion between chromosomes 2 and 4 occurred early
(already present in passage 8 cells) and is maintained.
Murine epidermal keratinocytes in culture have a ten-
dency to became tetraploid [14,18]; however, COCA
showed to be genetically mores t a b l et h a np r e v i o u s l y
published cell lines [18] and was still diploid at passage
8 (Table 1).
Formation of conventional and 3D epidermal
differentiation in vitro models
The epidermis is a multilayered epithelium where the
process of terminal differentiation takes place as the
committed cells in the basal proliferative compartment
arrest proliferation and move upwards towards the epi-
dermal surface. This process is accompanied by changes
in the expression of keratins and other proteins. Keratin
5 (K5) is expressed in the basal layer, where prolifera-
tion occurs, and marks undifferentiated cells. Once the
cells start the differentiation program they cease the
expression of K5 and start the synthesis of the keratin
K10, which is considered as an early marker of differen-
tiation in vivo and in vitro. Terminal differentiation is
indicated by the expression of loricrin and filaggrin. The
keratin K6 is induced in the interfollicular epidermis as
consequence of inflammatory and/or hyperproliferative
stimuli, and in many circumstances this is in parallel
with reduced K10 expression and expansion of K5 to
suprabasal layers.
Keratinocytes can be induced to differentiate in vitro by
increasing the concentration of calcium in the culture
medium [20-22]. To evaluate the potential of COCA to
differentiate we replaced the low calcium medium (0.07
mM) for a differentiation medium containing a high con-
centration of calcium (1.2 mM). As early as 24 hours in
1.2 mM calcium differentiation medium, keratinocytes
start to flatten (Figure 1A, upper row panels) and to
establish cell-cell contacts. Upon calcium elevation,
COCA mouse keratinocytes in all passages studied (pas-
sage 21, 51 and 76), displayed an arrest in proliferation
(Figure 1B) and a similar pattern of differentiation mar-
ker expression: K10 expressing cells are detected at 24-48
hours and loricrin positive cells at 48-72 hours in differ-
entiation media (Figure 1A, immunofluorescence panels).
Cells from passage 51 and 76 growing in low calcium
medium displayed an increased proliferation rate as com-
pared to that of passage 21, this could be due to further
adaptation of the cells occurring between passage 21 and
51. Still, cells at all passages tested readily responded
with an arrest in proliferation when switched for 24
hours to a high calcium media. Most importantly, after
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Passage n° Metaphases analysed Chromosome n° Chromosome rearrangements Sex
Range Modal number
8 10 38-43 40 der(4)T(2;4) XX
52 15 64-77 71 der(4)T(2;4) XXXX
77 15 67-79 75 der(4)T(2;4) + 2 centromeric fagments XXX
T: translocation.
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Figure 1 Differentiation of COCA murine epidermal keratinocytes. A) Phase contrast micrographs (upper panel) showing COCA murine
keratinocytes from passage 76 (P, denotes passage) growing in low (0.07 mM) or high (1.2 mM) calcium medium at the indicated times, and re-
stimulated to grow with low calcium medium for an additional 24 h. Expression of differentiation markers was studied by immunofluorescence.
In blue, nuclei stained with DAPI; in green, the early differentiation marker K10; in red, the terminal differentiation marker loricrin. Scale bar: 200
μm. All micrographs were taken at the same scale. B) Percentage of BrdU incorporation in keratinocytes growing under the indicated conditions.
At least 1,000 cells from 5-10 different fields were scored in each time point (mean ± standard error). Student’s t-test; * p < 0.05 vs. P21 in 0.07
mM Ca
2+; ♦ p < 0.05 vs. P21 in 24 h 1.2 mM Ca
2+.
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lated for 24 hours in the presence of low calcium growth
medium and, independently of the passages studied,
expression of terminal differentiation markers was
achieved and BrdU incorporation was minimal, demon-
strating that differentiation is associated to permanent
cell cycle withdrawal (Figure 1A, right column panels,
and Figure 1B).
Although useful, the above described in vitro differen-
tiation model has important limitations; in this sense,
3D models resemble the in vivo situation much more
closely. In these systems, the keratinocytes are organised
in a multiple layered structure, with a proliferating basal
layer that stratifies as it matures and differentiates. We
have followed a 3D epidermal in vitro model that avoids
the use of supporting cells, collagen matrix and non-
defined cultured media. Cell cultures of COCA in pas-
sage 76 were induced to differentiate by creating an air/
liquid interface. After three weeks a full epidermis-like
structure was formed (Figure 2A). K5 was expressed in
basal and suprabasal layer cells while K6 and K10 were
only expressed by suprabasal layers (Figure 2B-E).
Suprabasal layers express the terminal differentiation
markers loricrin and filaggrin (Figure 2D&2E). Prolifer-
ating cell nuclear antigen (PCNA) staining shows that
the layer of proliferating cells that maintain the architec-
ture of the culture locates at the base (Figure 2F). Lim-
itations to this 3D model affect K10 expression that is
patched rather that continuous, as well as that of the
terminal differentiation markers loricrin and filaggrin.
Also, the normal sequence of expression of these mar-
kers is not fully preserved.
K10 Filaggrin K10 Loricrin
PCNA K5
K10 K5 K10 K6
1 week 2 weeks 3 weeks A
B C
F
E D
Figure 2 Three-dimensional in vitro epidermal cell cultures using COCA keratinocytes. A) H&E staining showing the formation of a 3D in
vitro epidermal cell culture using passage 76 COCA keratinocytes. The micrographs show the progression of the culture for 1, 2 and 3 weeks
after inducing the cells to differentiate by creating an air/liquid interface. B-F) Immunofluorescence staining of 3 week 3D cultures. B) K5
expression is expanded to suprabasal layers reflecting the hyperproliferative nature of the model (for details see inset). C) K6 is expressed mostly
in suprabasal layers (for details see inset). B-E) K10 is expressed in suprabasal layers and some K10 positivity can be detected in the corneous
stratum. Loricrin (D) and filaggrin (E) are also expressed in suprabasal layers. PCNA staining (F) showed that proliferation is mostly restricted to
the basal layer cells. Dashed lines mark the contact of the basal layer of the 3D culture with the PCF membrane. Dotted lines mark the end of
the corneous stratum. Scale bars: 100 μm.
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epidermis in in vivo assays
To explore whether prolonged culture conditions might
have conferred tumorigenic potential to COCA cells we
performed in vivo tumorigenicity assays using immuno-
deficient mice [25-27]. In this assays, keratinocytes were
injected in the flanks of nu/nu mice alone or mixed
with dermal fibroblasts to help sustain keratinocyte
growth. After 4-6 months there was no external sign of
tumour growth and animals were sacrificed and studied
to search for any evidence of tumour formation. Experi-
ments using genetically modified murine keratinocytes
were done in parallel and yielded 100% tumour growth
by 2 months, both in the presence/absence of dermal
fibroblasts (data not shown).
To rule out the possibility that subcutaneous injection
is an adverse environment for non-genetically modified
keratinocytes to thrive we used a different approach, sili-
cone chambers implanted onto the back of immunodefi-
cient mice which might provide a more physiological
environment for the keratinocytes to grow. In these
grafting assays, keratinocytes are seeded on the subcuta-
neous fascia of immunodeficient mice with dermal fibro-
blasts. After 1 month of grafting, COCA keratinocytes
generated a fully differentiated epidermis-like structure
(Figure 3A). This epidermis displays some hyperplasia
due to increased proliferation as demonstrated by the
expansion of K5 to suprabasal layers, K6 expression and
high rate of BrdU incorporation (Figure 3B, C &3D).
However, expression of early and late differentiation
markers is maintained (K10 in Figure 3C-F, loricrin in
3E & filaggrin in 3F). No signs of dysplasia or malignant
transformation were evident. When the experiments
were done grafting genetically modified keratinocytes,
papillomas with evident signs of malignant transforma-
tion developed (data not shown).
Discussion
Three-dimensional models represent the most accurate
method of modelling skin complex biological processes
in vitro. Also, genetically modified mouse models have a
lot to offer in the study of skin disease research. How-
ever, the difficulties to establish long-term cultures of
murine epidermal keratinocytes have hindered the
development of murine 3D cultures.
We have established a non-transformed murine kerati-
nocyte cell line that grows on conventional cell culture
plastic dishes without the need of feeder cells or coating
matrix. Also, cell growth is done in easy-to-use com-
mercially available defined cell culture media. We have
termed this murine keratinocyte cell line COCA and we
show its capacity to grow in 3D in vitro models and to
reconstitute epidermis in cell grafting assays in vivo.
In agreement with previous studies [14,18], COCA
keratinocytes show a tendency to tetraploidy when sub-
cultured. SKY analyses revealed that while at passage 8
cells were still diploid, at passage 77 they were almost
tetraploid. However, COCA cells seem more stable than
previously reported cells that were nearly tetraploid
after 8 to 10 passages [18]. This could be partly due to
improved cell culture conditions or to the fact that
COCA cells were established from adult mice keratino-
cytes instead from newborn pups. SKY analyses also
revealed a clonal translocation between chromosomes 2
and 4 that occurred early in the culture.
All the same, these alterations in chromosome number
are not linked to defects in differentiation. When induced
to differentiate by raising the calcium concentration in
the culture media, COCA cells expressed the early differ-
entiation-specific keratin K10 and the terminal differen-
tiation marker loricrin, with timing and pattern
B
K5BrdU
K10Filaggrin F
K5K10
C
K6K10
D
K10Loricrin E
A
Figure 3 COCA keratinocytes regenerate an epidermis-like
structure in vivo upon grafting. COCA keratinocytes in passage 77
were grafted into silicon chambers placed in the back skin of
immunodeficient mice. H&E (A) and immunofluorescence (B-F)
staining of the epidermis formed 4 weeks after grafting. B&C) K5
was expressed mainly by basal keratinocytes but displayed some
expansion to suprabasal layers; however, BrdU-K5 positive cells were
located mainly in the basal layer (B). D) K6 was present in basal and
suprabasal layers and overlapped partially with the expression of the
early differentiation marker K10. C-F) K10 was not expressed in the
basal layer. Loricrin (E) and filaggrin (F) were expressed in suprabasal
layers. Scale bars: 100 μm.
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keratinocyte differentiation is accompanied by a perma-
nent arrest in proliferation. Similarly, COCA cells arrest
their proliferation when induced to differentiate by cal-
cium and they hardly re-enter in cell cycle when stimu-
lated again with low calcium growth medium [28]. This
is indicative of a postmitotic terminally differentiated
cell, characteristic of differentiated keratinocytes in vivo.
Next, we showed that COCA are also able to establish
3D models where keratinocytes are induced to differenti-
ate by creating an air/liquid interface. Even late passage
COCA keratinocytes (>75) are able to form an organised
epidermis-like structure where proliferating cells are situ-
ated in the basal layer and K10, loricrin and filaggrin
expressing differentiated cells locate at suprabasal layers.
There is an expansion in the expression of the basal kera-
tinocyte K5 to suprabasal layers, and expression of K6,
this could be indicative of increased proliferation. Also,
some alterations are present in the normal sequence of
differentiation marker expression. Of note, these altera-
tions affecting the expression of differentiation markers
K10, loricrin and filaggrin, were not observed in in vivo
experiments, pointing out to a possible experimental lim-
itation of the in vitro model. However, work done in our
laboratory with keratinocytes from murine models bear-
ing different genetic alterations show that these 3D in
vitro models are useful to study some of the characteris-
tics and behaviour of these cells (not shown).
In vivo assays using immunodeficient mice showed
that COCA cells are non-tumorigenic. This was also
supported by cell grafting assays where late passage
COCA keratinocytes were capable of growing a well-
preserved epidermal-like structure with no evident signs
of tumoral alterations.
Conclusions
We have generated an epidermal murine keratinocyte
cell line, termed COCA. We show that COCA keratino-
cytes can establish reproducible 3D models applicable to
the study of skin biology. The method we have followed
to obtain and culture this cell line can be used to suc-
cessfully develop keratinocyte cell lines from mice with
genetic modifications of interest in the field of skin dis-
ease. Also, COCA could be a good control when study-
ing the biological implications of these alterations.
Additional material
Additional file 1: SKY figures of representative metaphases from
COCA samples at the indicated passage numbers (P). Cells display a
stable translocation between chromosomes 2 and 4 (T(2;4)), and are
nearly tetraploid at P77.
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